Geneye Extra Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Geneye Extra
B
- Bel-Phen-Ergot (belladonna / ergotamine / phenobarbital)
- Bel-Tabs (belladonna / ergotamine / phenobarbital)
- Belcomp-PB (belladonna / caffeine / ergotamine / pentobarbital)
- belladonna / caffeine / ergotamine / pentobarbital
- belladonna / ergotamine / phenobarbital
- Bellamine (belladonna / ergotamine / phenobarbital)
- Bellamine S (belladonna / ergotamine / phenobarbital)
- Bellamor (belladonna / ergotamine / phenobarbital)
- Bellaphen-S (belladonna / ergotamine / phenobarbital)
- Bellaspas (belladonna / ergotamine / phenobarbital)
- Bellergal-S (belladonna / ergotamine / phenobarbital)
- bendroflumethiazide / rauwolfia serpentina
- benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- bitolterol
- Breo Ellipta (fluticasone / vilanterol)
- Brethaire (terbutaline)
- Brethine (terbutaline)
- Breyna (budesonide / formoterol)
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Bricanyl (terbutaline)
- Bronkometer (isoetharine)
- Bronkosol (isoetharine)
- Brovana (arformoterol)
- Budeprion (bupropion)
- Budeprion SR (bupropion)
- Budeprion XL (bupropion)
- budesonide / formoterol
- budesonide / formoterol / glycopyrrolate
- bupivacaine / ketamine / ketorolac
- Buproban (bupropion)
- bupropion
- bupropion / dextromethorphan
- bupropion / naltrexone
More about Geneye Extra (tetrahydrozoline ophthalmic)
- Geneye Extra consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic antihistamines and decongestants
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.